Dr. Fields has received consultant fees and speaking fees (more than $10,000) from Takeda Pharmaceuticals and has served as a paid investment consultant (less than $10,000) for Gerson Lehrman Group.
The New York City Rheumatology Objective Structured Clinical Examination: Five-year data demonstrates its validity, usefulness as a unique rating tool, objectivity, and sensitivity to change
Article first published online: 30 NOV 2009
Copyright © 2009 by the American College of Rheumatology
Arthritis Care & Research
Volume 61, Issue 12, pages 1686–1693, 15 December 2009
How to Cite
Berman, J. R., Lazaro, D., Fields, T., Bass, A. R., Weinstein, E., Putterman, C., Dwyer, E., Krasnokutsky, S., Paget, S. A. and Pillinger, M. H. (2009), The New York City Rheumatology Objective Structured Clinical Examination: Five-year data demonstrates its validity, usefulness as a unique rating tool, objectivity, and sensitivity to change. Arthritis & Rheumatism, 61: 1686–1693. doi: 10.1002/art.24738
- Issue published online: 30 NOV 2009
- Article first published online: 30 NOV 2009
- Manuscript Accepted: 30 JUL 2009
- Manuscript Received: 17 DEC 2008
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.